Kestrel Therapeutics Inc. announced it raised $7.5 Million in an initial filing from an offering of $40 Million
Jan 11, 2022•almost 4 years ago
Amount Raised
$7.5 Million
BostonBiotechnology
Company Information
Company
Kestrel Therapeutics
Location
Boston, Massachusetts, United States
About
Kestrel is discovering and developing new molecules to treat intractable cancers. We are starting with potent inhibitors of pan-oncogenic-RAS.
We rely on exceptional science, and our focus, always, is on patients.
Boston